FRLI: AI 评分 51/100 — AI 分析 (4月 2026)

Frélii, Inc. specializes in personalized nutrition and wellness programs delivered through its online platform. The company utilizes genetic data and lifestyle factors to create customized health plans and offers related products.

Key Facts: AI Score: 51/100 Sector: Technology

公司概况

概要：

Frélii, Inc. provides personalized, subscription-based nutrition and wellness programs, leveraging genetic data and lifestyle factors to tailor health plans. Operating within the application software sector, the company offers a platform for health assessments, nutritional guidance, and related products, targeting consumers seeking customized wellness solutions.

FRLI是做什么的？

Frélii, Inc., formerly known as Vican Resources, Inc. until its rebranding in March 2018, operates in the technology sector, specifically within the application software industry. The company is headquartered in Lehi, Utah, and focuses on delivering personalized nutrition and wellness programs through its frelii.com web platform. Frélii's core offering revolves around creating customized health assessments and nutrition plans, taking into account a range of factors including genetic data, individual physiology, environmental influences, and lifestyle choices. These plans are designed to provide users with tailored guidance on diet, exercise, and overall well-being. In addition to its personalized plans, Frélii also provides a suite of related products and services. These include lab diagnostic kits that allow users to gather relevant health data, compounding pharmacy products tailored to individual needs, and a range of nutritional and vitamin supplements designed to support the personalized nutrition plans. The company's business model is centered around subscription-based access to its platform and the sale of these related products. Frélii's competitive positioning is centered around its ability to offer a highly personalized approach to nutrition and wellness, differentiating itself from more generic wellness programs and supplement providers. The company aims to leverage technology and data to provide a more effective and tailored experience for its users.

FRLI的投资论点是什么？

Frélii, Inc. presents a unique investment opportunity within the personalized nutrition and wellness space. The company's focus on leveraging genetic data and lifestyle factors to create customized health plans offers a differentiated approach in a growing market. With a gross margin of 22.5%, there's potential for profitability as the company scales its subscription-based model. Key value drivers include expanding its user base through targeted marketing and partnerships, increasing subscription revenue, and introducing new product offerings such as advanced diagnostic kits and personalized supplements. However, potential investors should be aware of the risks associated with the company's OTC listing, including limited liquidity and disclosure. Furthermore, the company's negative profit margin of -15439.4% indicates significant challenges in achieving profitability. The company's high beta of 3.42 suggests high volatility. Success hinges on effective execution of its growth strategies and navigating the competitive landscape.

FRLI在哪个行业运营？

Frélii, Inc. operates within the rapidly expanding personalized nutrition and wellness market. This market is driven by increasing consumer awareness of the link between diet, lifestyle, and health outcomes. The global wellness market is estimated to be worth trillions of dollars, with personalized nutrition representing a significant growth segment. Competitors range from large nutrition and supplement companies to smaller, specialized firms offering genetic testing and personalized health plans. Frélii's success depends on its ability to differentiate itself through its technology platform, data-driven approach, and personalized customer experience. The company faces competition from companies like ANVV (Anavex Life Sciences Corp.), CGLO (Cogilo Technologies Corp.), EDTA (Edita Food Industries S.A.E.), GEMSF (GEMS Science Fund I, Inc.), and GOLQ (Gold Lion Holding Inc.).

Software - Application

Technology

FRLI有哪些增长机遇？

Expansion of Product Offerings: Frélii can expand its product line to include more advanced and specialized diagnostic kits. The market for genetic testing and personalized diagnostics is growing rapidly, with a projected market size of $13.8 billion by 2027. By offering a wider range of diagnostic tools, Frélii can attract new customers and increase revenue per user. This initiative can be implemented within the next 12-18 months, requiring investment in research and development and partnerships with diagnostic labs.
Strategic Partnerships: Collaborating with healthcare providers, fitness centers, and corporate wellness programs can significantly expand Frélii's reach and customer base. The corporate wellness market is a multi-billion dollar industry, with companies increasingly investing in employee health programs. By partnering with these organizations, Frélii can offer its personalized nutrition plans as part of a comprehensive wellness package. These partnerships can be established within the next 6-12 months, requiring a dedicated sales and marketing effort.
International Market Expansion: Frélii can explore opportunities to expand its services to international markets, particularly in regions with a growing interest in personalized health and wellness. The global wellness market is expanding rapidly, with significant growth potential in Asia-Pacific and Europe. Adapting its platform and services to meet the specific needs and regulations of different countries can open up new revenue streams. This expansion can be phased in over the next 2-3 years, starting with pilot programs in select markets.
Development of a Mobile App: Creating a user-friendly mobile app can enhance customer engagement and provide a more convenient way for users to access their personalized nutrition plans and track their progress. Mobile health apps are becoming increasingly popular, with millions of users worldwide. An app can also enable Frélii to collect more data on user behavior and preferences, further improving the personalization of its services. The app can be developed and launched within the next 9-12 months, requiring investment in software development and user interface design.
Leveraging AI and Machine Learning: Implementing AI and machine learning technologies can enhance the accuracy and effectiveness of Frélii's personalized nutrition plans. AI can be used to analyze large datasets of genetic and lifestyle information to identify patterns and predict individual responses to different dietary interventions. This can lead to more precise and effective recommendations, improving customer satisfaction and retention. AI integration can be implemented in phases over the next 12-24 months, requiring investment in data science expertise and AI infrastructure.

Frélii, Inc. operates in the personalized nutrition and wellness market, offering customized health plans based on genetic data and lifestyle factors.
The company's platform, frelii.com, provides health assessments, nutrition plans, lab diagnostic kits, and nutritional supplements.
Frélii, Inc. was rebranded from Vican Resources, Inc. in March 2018, signaling a strategic shift towards personalized wellness.
The company's gross margin stands at 22.5%, indicating potential for profitability with increased scale and operational efficiency.
Frélii, Inc. has a market capitalization of $0.00B, highlighting its early-stage growth potential and associated risks.

FRLI提供哪些产品和服务？

Provide personalized nutrition and wellness programs.
Offer health assessments based on genetic data and lifestyle factors.
Create customized nutrition plans tailored to individual needs.
Provide access to lab diagnostic kits for health data collection.
Offer compounding pharmacy products.
Sell nutritional and vitamin supplements.
Operate an online platform (frelii.com) for program delivery and product sales.

FRLI如何赚钱？

Subscription-based access to personalized nutrition and wellness programs.
Revenue from the sale of lab diagnostic kits.
Sales of compounding pharmacy products.
Sales of nutritional and vitamin supplements.

Individuals seeking personalized nutrition and wellness solutions.
Health-conscious consumers interested in genetic-based health plans.
Customers looking for customized vitamin and supplement regimens.
Users of the frelii.com web platform.

Proprietary algorithms for personalized nutrition plan creation.
Access to genetic data and personalized health information.
Subscription-based revenue model providing recurring income.
Established online platform (frelii.com) for program delivery and product sales.

什么因素可能推动FRLI股价上涨？

Upcoming: Potential partnerships with healthcare providers or fitness centers could expand market reach.
Upcoming: Launch of a mobile app to enhance user engagement and data collection.
Ongoing: Expansion of product offerings, such as advanced diagnostic kits and personalized supplements.
Ongoing: Increasing consumer awareness of personalized nutrition and wellness.
Ongoing: Leveraging AI and machine learning to improve the accuracy of personalized nutrition plans.

FRLI的主要风险是什么？

Potential: Limited liquidity due to OTC Other listing may hinder trading activity.
Potential: Negative profit margin (-15439.4%) raises concerns about financial sustainability.
Ongoing: Competition from larger nutrition and supplement companies could erode market share.
Potential: Changing regulations in the health and wellness industry may impact business operations.
Potential: Data privacy and security breaches could damage reputation and erode customer trust.

FRLI的核心优势是什么？

Personalized nutrition plans based on genetic data.
Subscription-based revenue model.
Online platform for program delivery and product sales.
Offers lab diagnostic kits and compounding pharmacy products.

FRLI的劣势是什么？

Limited market capitalization ($0.00B).
Negative profit margin (-15439.4%).
OTC listing with limited liquidity and disclosure.
Small number of employees (10).

FRLI有哪些机遇？

Expansion of product offerings (e.g., advanced diagnostic kits).
Strategic partnerships with healthcare providers and fitness centers.
International market expansion.
Development of a mobile app.

FRLI面临哪些威胁？

Competition from larger nutrition and supplement companies.
Changing regulations in the health and wellness industry.
Potential data privacy and security breaches.
Economic downturn affecting consumer spending on wellness products.

FRLI的竞争对手是谁？

Anavex Life Sciences Corp. — Focuses on developing treatments for neurodegenerative diseases. — (ANVV)
Cogilo Technologies Corp. — Specializes in AI-powered software solutions for various industries. — (CGLO)
Edita Food Industries S.A.E. — A leading packaged food company in Egypt. — (EDTA)
GEMS Science Fund I, Inc. — Venture capital fund investing in science and technology companies. — (GEMSF)
Gold Lion Holding Inc. — Operates in the consumer products and e-commerce space. — (GOLQ)

Key Metrics

MoonshotScore: 51/100

Company Profile

CEO: Ian Geran Jenkins
Headquarters: Lehi, US
Employees: 10
Founded: 2009

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Frélii, Inc. do?

Frélii, Inc. is a technology company operating in the personalized nutrition and wellness sector. The company provides customized health assessments and nutrition plans based on individual genetic data, physiology, environmental factors, and lifestyle choices. These plans are delivered through its online platform, frelii.com, which also offers lab diagnostic kits, compounding pharmacy products, and nutritional supplements. Frélii's business model centers around subscription-based access to its platform and the sale of related health and wellness products, targeting consumers seeking tailored solutions for their health needs.

What do analysts say about FRLI stock?

There is currently no available analyst coverage or consensus on Frélii, Inc. (FRLI) stock. Given its OTC Other listing and limited market capitalization, the company is not widely followed by analysts. Investors should conduct their own thorough research and due diligence before considering an investment in FRLI. Key valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, are either not meaningful or unavailable due to the company's negative profitability and limited financial disclosure. Growth considerations should focus on the company's ability to expand its user base, increase subscription revenue, and achieve profitability.

What are the main risks for FRLI?

The main risks for Frélii, Inc. include its OTC Other listing, which implies limited liquidity and disclosure, increasing the potential for volatility and manipulation. The company's negative profit margin (-15439.4%) raises concerns about its financial sustainability and ability to fund future growth. Competition from larger, more established nutrition and supplement companies poses a significant threat to its market share. Furthermore, changing regulations in the health and wellness industry, as well as potential data privacy and security breaches, could negatively impact its business operations and reputation. Investors should carefully consider these risks before investing in FRLI.